RU2020111236A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2020111236A3 RU2020111236A3 RU2020111236A RU2020111236A RU2020111236A3 RU 2020111236 A3 RU2020111236 A3 RU 2020111236A3 RU 2020111236 A RU2020111236 A RU 2020111236A RU 2020111236 A RU2020111236 A RU 2020111236A RU 2020111236 A3 RU2020111236 A3 RU 2020111236A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13517108P | 2008-07-17 | 2008-07-17 | |
| US61/135.171 | 2008-07-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019125376A Division RU2719199C1 (ru) | 2008-07-17 | 2019-08-12 | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2020111236A3 true RU2020111236A3 (https=) | 2021-09-21 |
| RU2020111236A RU2020111236A (ru) | 2021-09-21 |
Family
ID=42005671
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011105821/10A RU2536938C2 (ru) | 2008-07-17 | 2009-07-17 | Применение пептида ggf2 в лечении или профилактике сердечной недостаточности у млекопитающего |
| RU2014141514A RU2698090C2 (ru) | 2008-07-17 | 2014-10-14 | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности |
| RU2019125376A RU2719199C1 (ru) | 2008-07-17 | 2019-08-12 | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности |
| RU2020111236A RU2020111236A (ru) | 2008-07-17 | 2020-03-18 | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011105821/10A RU2536938C2 (ru) | 2008-07-17 | 2009-07-17 | Применение пептида ggf2 в лечении или профилактике сердечной недостаточности у млекопитающего |
| RU2014141514A RU2698090C2 (ru) | 2008-07-17 | 2014-10-14 | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности |
| RU2019125376A RU2719199C1 (ru) | 2008-07-17 | 2019-08-12 | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US20110166068A1 (https=) |
| EP (3) | EP3338791B1 (https=) |
| JP (5) | JP5797112B2 (https=) |
| CN (3) | CN107019794B (https=) |
| AU (3) | AU2009292216B2 (https=) |
| BR (1) | BRPI0916442A2 (https=) |
| CA (1) | CA2731113A1 (https=) |
| DK (2) | DK2320933T3 (https=) |
| ES (2) | ES2763184T3 (https=) |
| MX (2) | MX384378B (https=) |
| PL (2) | PL3338791T3 (https=) |
| RU (4) | RU2536938C2 (https=) |
| WO (1) | WO2010030317A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110166068A1 (en) * | 2008-07-17 | 2011-07-07 | Acorda Therapeutics, Inc. | Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure |
| EP3777878A1 (en) | 2008-08-15 | 2021-02-17 | Acorda Therapeutics, Inc. | Compositions and methods for treatment during non-acute periods following cns neurological injury |
| EP2370458B1 (en) * | 2008-11-28 | 2014-10-15 | Zensun (Shanghai) Science and Technology Limited | Neuregulin peptides and their use |
| NZ625673A (en) | 2009-10-14 | 2015-11-27 | Acorda Therapeutics Inc | Use of a neuregulin to treat peripheral nerve injury |
| WO2013053076A1 (en) * | 2011-10-10 | 2013-04-18 | Zensun （Shanghai）Science & Technology Limited | Compositions and methods for treating heart failure |
| EP3842059A1 (en) * | 2012-03-30 | 2021-06-30 | Acorda Therapeutics, Inc. | Ggf2 to treat surgical peripheral nerve injury or neuropathic pain therefrom |
| JP6542678B2 (ja) * | 2013-03-06 | 2019-07-10 | アコーダ セラピューティクス インコーポレイテッド | 心不全の治療または予防のためのニューレグリンまたはその断片の治療的投与の方法 |
| EP3895724B1 (en) | 2013-05-22 | 2025-06-25 | Zensun (Shanghai) Science and Technology, Co., Ltd. | Extended release of neuregulin for treating heart failure |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| CN111407882A (zh) * | 2014-10-17 | 2020-07-14 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物 |
| WO2017053794A1 (en) | 2015-09-25 | 2017-03-30 | Sawyer Douglas B | Methods for treating cardiac injury |
| WO2017182500A1 (en) * | 2016-04-19 | 2017-10-26 | Leibniz-Institut Für Alternsforschung - Fritz-Lipmann-Institut E.V. (Fli) | Neuregulin for the treatment and/or prevention of tumors of the nervous system |
| CN110835368A (zh) * | 2018-08-15 | 2020-02-25 | 上海泽生科技开发股份有限公司 | 神经调节蛋白多肽片段及其用途 |
| AR121035A1 (es) | 2019-04-01 | 2022-04-13 | Lilly Co Eli | Compuestos de neuregulina-4 y métodos de uso |
| JP2022547335A (ja) * | 2019-09-16 | 2022-11-11 | ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． | 組換えヒトニューレグリン誘導体及びその使用 |
| WO2023070078A1 (en) * | 2021-10-22 | 2023-04-27 | The Research Institute At Nationwide Children's Hospital | Neuregulin for protection against respiratory viral infection and post-viral disease |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115554B1 (en) * | 1993-05-06 | 2006-10-03 | Acorda Therapeutics, Inc. | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US6087323A (en) | 1992-04-03 | 2000-07-11 | Cambridge Neuroscience, Inc. | Use of neuregulins as modulators of cellular communication |
| US7037888B1 (en) | 1992-04-03 | 2006-05-02 | Acorda Therapeutics, Inc. | Methods for treating muscle diseases and disorders |
| US5811098A (en) * | 1992-11-24 | 1998-09-22 | Bristol-Myers Squibb Company | Antibodies to HER4, human receptor tyrosine kinase |
| US5912326A (en) | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
| US6136558A (en) * | 1997-02-10 | 2000-10-24 | Genentech, Inc. | Heregulin variants |
| US6051401A (en) | 1998-07-28 | 2000-04-18 | Bayer Corporation | Methods and constructs for protein expression |
| PL203689B1 (pl) | 1998-09-25 | 2009-11-30 | Cubist Pharmaceuticals | Zastosowanie daptomycyny |
| AUPP785098A0 (en) * | 1998-12-21 | 1999-01-21 | Victor Chang Cardiac Research Institute, The | Treatment of heart disease |
| US6635249B1 (en) * | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| CN1138785C (zh) * | 1999-06-04 | 2004-02-18 | 周明东 | 生长因子神经调节蛋白及其类似物的新应用 |
| JP2003527337A (ja) | 1999-11-12 | 2003-09-16 | エントレメッド インコーポレイテッド | 抗血管新生スケジュールに基づく治療薬の投与方法 |
| AU2001274947B2 (en) | 2000-05-23 | 2006-08-17 | Acorda Therapeutics, Inc. | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| CU23157A1 (es) * | 2001-01-03 | 2006-07-18 | Ct Ingenieria Genetica Biotech | COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL |
| EP1569689A4 (en) | 2002-01-18 | 2009-08-05 | Novartis Vaccines & Diagnostic | IL2 / ANTI-HER2-ANTIBODY COMBINATION THERAPY AGAINST CANCER, which is characterized by overexpression of the HER2-RECEPTOR PROTEIN |
| AU2002304965A1 (en) * | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
| WO2006087420A2 (en) * | 2005-02-18 | 2006-08-24 | Orion Corporation | A method for treating heart failure |
| JP2006265244A (ja) | 2005-03-23 | 2006-10-05 | Pfizer Prod Inc | Ｃｔｌａ４抗体とホルモン治療を用いた前立腺癌の治療 |
| US7776817B2 (en) | 2005-09-02 | 2010-08-17 | Morehouse School Of Medicine | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| US20070213264A1 (en) * | 2005-12-02 | 2007-09-13 | Mingdong Zhou | Neuregulin variants and methods of screening and using thereof |
| ES2530526T3 (es) * | 2005-12-30 | 2015-03-03 | Zensun Shanghai Science And Technology Ltd | Liberación extendida de neurregulina para mejorar la función cardíaca |
| WO2009108390A2 (en) | 2008-02-29 | 2009-09-03 | Acorda Therapeutics, Inc. | Method for achieving desired glial growth factor 2 plasma levels |
| US20110166068A1 (en) | 2008-07-17 | 2011-07-07 | Acorda Therapeutics, Inc. | Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure |
| NZ625673A (en) | 2009-10-14 | 2015-11-27 | Acorda Therapeutics Inc | Use of a neuregulin to treat peripheral nerve injury |
| EP2603221A4 (en) | 2010-08-13 | 2014-02-26 | Univ Georgetown | GGF2 AND METHOD FOR ITS APPLICATION |
| EP3842059A1 (en) | 2012-03-30 | 2021-06-30 | Acorda Therapeutics, Inc. | Ggf2 to treat surgical peripheral nerve injury or neuropathic pain therefrom |
-
2009
- 2009-07-17 US US13/055,397 patent/US20110166068A1/en not_active Abandoned
- 2009-07-17 MX MX2015001826A patent/MX384378B/es unknown
- 2009-07-17 WO PCT/US2009/004130 patent/WO2010030317A2/en not_active Ceased
- 2009-07-17 EP EP17209369.2A patent/EP3338791B1/en active Active
- 2009-07-17 BR BRPI0916442-1A patent/BRPI0916442A2/pt not_active IP Right Cessation
- 2009-07-17 CN CN201710109733.2A patent/CN107019794B/zh not_active Expired - Fee Related
- 2009-07-17 EP EP09813336.6A patent/EP2320933B1/en not_active Not-in-force
- 2009-07-17 RU RU2011105821/10A patent/RU2536938C2/ru active
- 2009-07-17 AU AU2009292216A patent/AU2009292216B2/en not_active Ceased
- 2009-07-17 MX MX2011000696A patent/MX2011000696A/es active IP Right Grant
- 2009-07-17 ES ES17209369T patent/ES2763184T3/es active Active
- 2009-07-17 JP JP2011518734A patent/JP5797112B2/ja not_active Expired - Fee Related
- 2009-07-17 DK DK09813336.6T patent/DK2320933T3/en active
- 2009-07-17 PL PL17209369T patent/PL3338791T3/pl unknown
- 2009-07-17 EP EP19197381.7A patent/EP3632459A1/en not_active Withdrawn
- 2009-07-17 DK DK17209369.2T patent/DK3338791T3/da active
- 2009-07-17 CN CN2009801360798A patent/CN102159236A/zh active Pending
- 2009-07-17 CN CN201510010273.9A patent/CN104623633A/zh active Pending
- 2009-07-17 CA CA2731113A patent/CA2731113A1/en not_active Abandoned
- 2009-07-17 ES ES09813336.6T patent/ES2664394T3/es active Active
- 2009-07-17 PL PL09813336T patent/PL2320933T3/pl unknown
-
2013
- 2013-05-29 US US13/904,654 patent/US9198951B2/en active Active
-
2014
- 2014-10-14 RU RU2014141514A patent/RU2698090C2/ru active
-
2015
- 2015-01-27 JP JP2015013248A patent/JP6189879B2/ja not_active Expired - Fee Related
- 2015-05-27 AU AU2015202877A patent/AU2015202877B2/en not_active Ceased
- 2015-10-30 US US14/928,124 patent/US9956266B2/en active Active
-
2017
- 2017-05-26 AU AU2017203528A patent/AU2017203528A1/en not_active Abandoned
- 2017-08-03 JP JP2017150365A patent/JP2017200949A/ja active Pending
-
2018
- 2018-03-29 US US15/940,250 patent/US20180280477A1/en not_active Abandoned
-
2019
- 2019-07-03 JP JP2019124501A patent/JP2019196370A/ja active Pending
- 2019-08-12 RU RU2019125376A patent/RU2719199C1/ru active
- 2019-09-09 US US16/564,739 patent/US11235031B2/en not_active Expired - Fee Related
-
2020
- 2020-03-18 RU RU2020111236A patent/RU2020111236A/ru unknown
-
2021
- 2021-11-04 JP JP2021179961A patent/JP2022023208A/ja active Pending